back to Australia directory
australia clinical guidance

Syphilis — recognition, serology interpretation, and management

A detailed Australian summary of syphilis — recognition, serology interpretation, and management, with source-attributed priorities, a practical workflow, safety escalation and state or territory implementation boundaries.

JurisdictionAustralia
Source check2026-08-20
Clinical reviewiatroX editorial team · Clinical editorial review · reviewed 2026-08-20 · due 2027-08-20
AudienceHealthcare professionals practising in Australia
This is an iatroX educational summary of named Australia sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Apply current TGA product information, PBS restrictions, state or territory law, local referral criteria, formulary and antimicrobial policy. A national recommendation does not create uniform service access.

Scope

Test with treponemal and non-treponemal serology interpreted together, considering stage, prior treatment, pregnancy and the early infection window. Examine for chancre, rash, mucosal lesions, neurological, ocular and otic symptoms and test for HIV and other STIs. This summary is limited to the population, decisions and escalation boundaries stated in the named source.
sources for this section:Australian STI Guidelines

The Bottom Line

  • Test with treponemal and non-treponemal serology interpreted together, considering stage, prior treatment, pregnancy and the early infection window.
  • Examine for chancre, rash, mucosal lesions, neurological, ocular and otic symptoms and test for HIV and other STIs.
  • Early infection can have negative serology, so repeat testing or direct lesion PCR may be required after high-risk compatible exposure.
  • Treat according to stage using the Australian STI guideline and document the baseline quantitative titre for response monitoring.
sources for this section:Australian STI Guidelines

Practical clinical workflow

1

Topic-specific assessment action

Test with treponemal and non-treponemal serology interpreted together, considering stage, prior treatment, pregnancy and the early infection window.
2

Topic-specific diagnostic action

Treat according to stage using the Australian STI guideline and document the baseline quantitative titre for response monitoring.
3

Topic-specific management action

Coordinate partner notification and follow-up titres and involve public health as required, with urgent specialist care in pregnancy.
4

Topic-specific follow-through

A fourfold non-treponemal titre change is used to assess response or reinfection, interpreted with stage and laboratory method.
sources for this section:Australian STI Guidelines

Safety boundaries and escalation

  • Visual, hearing or neurological symptoms, cardiovascular involvement, congenital exposure or severe treatment reaction requires urgent specialist assessment.
  • Jarisch–Herxheimer reaction can occur after treatment and needs explanation, particularly in pregnancy where fetal monitoring may be indicated.
sources for this section:Australian STI Guidelines

Implementation

The named source is national or binational guidance used in Australia, but referral access, public-health directions, formularies and funded services can still differ by state, territory and health service. Check current TGA product information for medicines. Offer culturally safe care and use the NACCHO–RACGP National Guide where Aboriginal and Torres Strait Islander preventive or chronic-care recommendations differ.
sources for this section:Australian STI Guidelines

Clinical use boundary

This independently written summary is not an official guideline. Check the linked source version, current TGA-approved product information where medicines are involved, and the applicable state, territory and local pathway at the point of care.

sources for this section:Australian STI Guidelines

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Australasian Society for HIV, Viral Hepatitis and Sexual Health MedicineAustralian STI Management Guidelines for Use in Primary CareLiving web guideline checked 2026-08-20 · accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page’s provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what—if anything—you may change. Suggestions are never inserted automatically.Browse the Australia question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.